(Q47926002)

6 February 2018

title

Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica (English)

1 reference

6 February 2018

author name string

Bhupendra O Khatri

1

1 reference

6 February 2018

John Kramer

2

1 reference

6 February 2018

Mary Dukic

3

1 reference

6 February 2018

Mauricio Palencia

4

1 reference

6 February 2018

William Verre

5

1 reference

6 February 2018

publication date

9 April 2012

1 reference

6 February 2018

Journal of Clinical Apheresis

published in

1 reference

6 February 2018

volume

27

1 reference

6 February 2018

issue

4

1 reference

6 February 2018

page(s)

183-192

1 reference

6 February 2018

The clinical course of neuromyelitis optica (Devic's syndrome).

cites work

1 reference

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

21 January 2018

1 reference

Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status

21 January 2018

1 reference

Western vs optic-spinal MS: two diseases, one treatment?

21 January 2018

1 reference

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients

21 January 2018

1 reference

Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

21 January 2018

1 reference

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers

21 January 2018

1 reference

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum

21 January 2018

1 reference

Neuromyelitis optica: current concepts

21 January 2018

1 reference

Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial

21 January 2018

1 reference

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

21 January 2018

1 reference

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

21 January 2018

1 reference

Neuromyelitis optica: diagnosis, pathogenesis, and treatment

21 January 2018

1 reference

Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.

21 January 2018

1 reference

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

21 January 2018

1 reference

A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset

21 January 2018

1 reference

Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica?

21 January 2018

1 reference

The spectrum of neuromyelitis optica: a case of NMO with extensive brain stem involvement

21 January 2018

1 reference

Mechanical ventilation and tracheostomy in multiple sclerosis

21 January 2018

1 reference

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica

21 January 2018

1 reference

Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder

21 January 2018

1 reference

Devic disease and thymoma with anti-central nervous system and antithymus antibodies

21 January 2018

1 reference

Intermittent plasmapheresis prevents recurrence in neuromyelitis optica

21 January 2018

1 reference

Plasma exchange in chronic progressive multiple sclerosis: a long-term study

21 January 2018

1 reference

Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures

21 January 2018

1 reference

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

Beneficial plasma exchange response in central nervous system inflammatory demyelination

21 January 2018

1 reference

Central venous catheter-related thrombosis: a systematic review

21 January 2018

1 reference

Clinical outcome measures for research in multiple sclerosis

21 January 2018

1 reference

Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis

21 January 2018

1 reference

Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis.

21 January 2018

1 reference

Comparison of IVIg and PLEX in patients with myasthenia gravis.

21 January 2018

1 reference

Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.

21 January 2018

1 reference

Quo vadis haemapheresis. Current developments in haemapheresis

21 January 2018

1 reference

Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica.

21 January 2018

1 reference

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.

21 January 2018

1 reference

OSMS is NMO, but not MS: proven clinically and pathologically

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCA.21215

1 reference

6 February 2018

release_pydky2rzjbgvditmup3kaxuepm

Fatcat ID

0 references

1 reference

6 February 2018